Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • mghcareers
    Junior Member
    • Nov 2013
    • 1

    PROGRAMMER ANALYST Opportunity at Massachusetts General Hospital in Boston!

    The MGH Pathology Department is a leader in the application of genomic technologies to the study of human disease, covering diverse fields such as personalized cancer medicine, integrative tumor profiling and targeted genome editing. We are seeking a highly motivated individual to work with our team of clinicians, biologists and statisticians to employ and develop computational tools for the analysis of high-dimensional clinical and research data. The successful candidate will join a thriving bioinformatics community and become involved in a range of ongoing efforts, with examples including: correlation of clinical outcomes with high-throughput tumor DNA sequencing data (http://abcnews.go.com/video/playerIndex?id=7740568), analysis of epigenome-wide profiling data from experimental cancer model systems (http://www.ncbi.nlm.nih.gov/pubmed/20569696) and optimization of genome engineering tools (http://www.ncbi.nlm.nih.gov/pubmed/21822273).


    Principal Duties:
    •Work with clinicians, basic scientists and computational biologists to evaluate, select and apply bioinformatics tools for high-dimensional biomedical data
    •Write software to implement novel analysis algorithms developed by members of our group
    •Maintain analysis pipelines
    •Produce software documentation for developers and end-users
    •Participate in collaborative research projects with investigators at MGH, the Broad Institute and other partner institutions


    Skills Required:

    Required:
    •Strong analytical skills
    •Algorithm development and programming experience
    •Desire and proven ability to work in multidisciplinary teams
    •Excellent written and oral communication skills, including the ability to communicate technical concepts to a non-technical audience


    Preferred:
    •Formal software engineering experience
    •Experience with high-level scripting languages (R and Python preferred) and Linux
    •Familiarity with molecular biology concepts
    •Experience with high-dimensional biomedical data and technology platforms


    Required Education:
    Required: BS

    Preferred: BS/MS in the quantitative or physical sciences, or related fields


    Experience:
    Preferred: 1+ years working with high-dimensional biological datasets

    If interested, please visit www.mghcareers.org to apply for job ID # 2245571, or click here

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:41 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...